BOC Sciences Reports Its Antibody Modification and Conjugation Technologies in Detail

The chief technician of BOC Sciences ADC development center recently reported some detailed information regarding its antibody modification and conjugation technologies, bringing the audience and customers a better understanding of how BOC Sciences has contributed to the ADC industry.

BOC Sciences Honored To Assist in the Antibody Research With High-Quality Chemicals

BOC Sciences' chemical products have been applied in a wide range of research projects and helped achieve groundbreaking breakthroughs.

BOC Sciences Declares the Availability of 10,000 Impurities, All in Stock!

BOC Sciences recently confirmed to its customers that over 10,000 impurities are now in stock, ready for immediate delivery.

AxisPharm's research in the field of bioanalysis and PK drive

AxisPharm bioanalytical chemistry department specializes in developing and validating robust bioanalytical methods for PK/TK sample analysis of small molecules, proteins, peptides, and metabolites using LCMS/MS (HPLC, UPLC, on-line SPE), HPLC/UV, and HPLC/FL.

MicrobioSeq Announces the Launch of the Phage Whole-Genome Sequencing Service

CD Genomics RNA-Solutions Platform Now Provides Whole Transcriptome Sequencing Service

CD Formulation Plays a Role in Developing Drug Delivery Systems

Alfa Chemistry: Expertise in Perovskite Quantum Dot Supply

Applications of Liposomal Drug Delivery System Technology

Mxene Materials Help Unlock Future Nanotechnologies

Genezen delivers next phase of cGMP lentiviral and retroviral vector production facility expansion

Genezen has completed another expansion at its viral vector process development and cGMP vector production facility in Fishers, Indiana (US).

Genedata Biologics Usage Expanded by Sanofi for Platformization of HT Multi-Specific Antibody Engineering

Global Biopharma leader drives digital innovation and AI-based biopharma R&D by expanding footprint of Genedata Biopharma Platform

Amphista Therapeutics partners with Domainex to advance portfolio of drug discovery projects targeting protein degradation

Amphista Therapeutics Ltd has selected Domainex Ltd as one of its trusted partners to provide integrated drug discovery services to support its research programmes. Domainex will provide expertise in protein production, assay biology and medicinal chemistry.

Quotient Sciences Expands UK Facilities to Support the Delivery of Translational Pharmaceutics® Programs

Company increases laboratory and clinical capacity to meet demand for fully integrated drug development capabilities

LILLY RECEIVES MHRA MARKETING AUTHORISATION FOR BARICITINIB (OLUMIANT®) FOR THE TREATMENT OF SEVERE ALOPECIA AREATA (AA) IN ADULT PATIENTS

Absolute Biotech Launches to Offer Antibody Reagents, Services and Expertise to Researchers Worldwide

Absolute Biotech launched today as a unified company joining together leading antibody-centric brands: Absolute Antibody, LSBio, Kerafast, Nordic-MUbio, Everest Biotech and Exalpha from around the world.

dMed | Clinipace announce corporate name change to Caidya

dMed |Clinipace, the established clinical research organization serving global innovators, such as biotechs, announced today that it is changing its corporate name to Caidya

LIQUID STABLE, MULTI-LEVEL CLINICAL REFERENCE MATERIALS FOR TOXICOLOGY TESTING AVAILABLE FROM VERICHEM LABOTATORIES

VERICHEM announced the availability of ready-to-use, multi-level, clinical reference materials for use with Toxicology assays on a wide array of diagnostic testing systems.

Announcing the 2022 Founder-Led Biotech Summit

Pillar VC and Petri have announced the 2022 Founder-Led Biotech Summit will take place during the week of October 31–November 4. This free, virtual event will be open to biotech founders, PhDs, scientists, investors, and leaders from anywhere in the world.

BioIVT Announces Global eCommerce Collaboration With Charles River Laboratories Avian Vaccine Services

Charles River Avian products, which are used for virus research and to produce veterinary and human vaccines, are now available through the BioIVT Digital Portal.